
Benefits of Stratified Analysis by Genomic Markers
1. Biological Relevance
Risk Stratification: If your 4 genomic markers represent different risk categories (e.g., high-risk, standard-risk, low-risk, ultra-high-risk), separate analyses can reveal microbiome patterns specific to each risk group
Mechanism Discovery: Different genomic profiles may have distinct microbiome signatures that would be masked in a combined analysis
2. Statistical Power
Homogeneous Groups: More homogeneous subgroups can reveal stronger associations that might be diluted in a heterogeneous population
Reduced Noise: Removing inter-group variation can help identify intra-group patterns
3. Clinical Translation
Personalized Medicine: Results can inform risk-specific microbiome interventions
Biomarker Development: Group-specific microbiome signatures could serve as additional biomarkers
Potential Drawbacks
1. Sample Size Reduction
Each subgroup will have fewer samples, potentially reducing statistical power
Some groups might be too small for robust analysis
2. Multiple Testing
4 separate analyses = 4x the multiple testing burden
Need appropriate correction for multiple comparisons
3. Interpretation Complexity
More results to interpret and synthesize
Risk of over-interpretation if groups are too small
Recommended Approach
1. Hybrid Strategy
Combined Analysis (all patients) → Baseline patterns
    ↓
Stratified Analysis (4 genomic groups) → Group-specific patterns
    ↓
Comparative Analysis → Differences between groups
2. Implementation in Your System
You could add this as an analysis configuration option:
// In your analysis editor
<div class="form-check">
    <input class="form-check-input" type="checkbox" id="stratifyByGenomics">
    <label class="form-check-label" for="stratifyByGenomics">
        <strong>Stratify by Genomic Markers</strong><br>
        <small class="text-muted">Perform separate analyses for each genomic risk group</small>
    </label>
</div>
3. Analysis Workflow
Combined Analysis: All patients together
Stratified Analyses: Separate MVA for each genomic group
Comparative Analysis: Statistical comparison between groups
Meta-Analysis: Synthesis of findings across groups
When This Approach Adds Value
✅ Recommended when:
Genomic markers represent distinct biological pathways
You have sufficient sample sizes per group (≥20-30 patients per group)
Research question involves personalized medicine
You want to identify group-specific microbiome signatures
❌ Not recommended when:
Sample sizes are too small per group
Genomic markers are highly correlated
Primary interest is in overall population patterns
Limited computational resources
Technical Implementation
You could extend your current system to support this by:
Adding stratification options to the analysis configuration
Creating parallel analysis pipelines for each genomic group
Implementing comparative statistics between groups
Generating integrated reports showing both combined and stratified results
Would you like me to help implement this stratified analysis feature in your system? I can add the configuration options and modify the analysis pipeline to support genomic marker-based stratification.